v3.26.1
Financial instruments
6 Months Ended
Jun. 30, 2026
Disclosure of detailed information about financial instruments [abstract]  
Financial instruments 10. Financial instruments
Valuation hierarchy of financial instruments carried at fair value on a recurring basis
The table below shows the classifications of our financial instruments by valuation method in accordance with IFRS 13 “Fair Value Measurement” at
30 June 2026 and 31 December 2025.
All instruments shown as being held at fair value have been classified as fair value through the profit and loss unless specifically footnoted.
30 June 2026
31 December 2025
Held at fair value
Held at
amortised
cost
US$m
Total
US$m
Held at fair value
Held at
amortised
cost
US$m
Total
US$m
Level 1(a)
US$m
Level 2(b)
US$m
Level 3(c)
US$m
Level 1(a)
US$m
Level 2(b)
US$m
Level 3(c)
US$m
Assets
Cash and cash equivalents(d)
2,788
6,125
8,913
3,725
5,147
8,872
Investments in equity shares and funds(e)
120
137
257
179
139
318
Other investments, including loans(f)
23
4
307
389
723
25
3
324
481
833
Trade and other financial receivables(g)
3
962
2,712
3,677
4
1,440
2,469
3,913
Loans to equity accounted units
799
799
800
800
Forward, option and embedded derivative
contracts: designated as hedges(h)
267
267
59
59
Forward, option and embedded derivative
contracts, not designated as hedges(h)
131
89
220
23
89
112
Derivatives related to net debt(i)
42
42
151
151
Liabilities
Trade and other financial payables(j)
(128)
(7,800)
(7,928)
(190)
(7,923)
(8,113)
Forward, option and embedded derivatives
contracts, designated as hedges(h)
(244)
(244)
(277)
(277)
Forward, option and embedded derivatives
contracts, not designated as hedges(h)
(102)
(166)
(268)
(68)
(162)
(230)
Derivatives related to net debt(i)
(304)
(304)
(231)
(231)
Other financial liabilities
(136)
(136)
(66)
(66)
(a)Valuation is based on unadjusted quoted prices in active markets for identical financial instruments.
(b)Valuation is based on inputs that are observable for the financial instruments, which include market quoted FX rates, credit default spread, quoted prices for similar instruments or
identical instruments in markets which are not considered to be active, or inputs, either directly or indirectly based on observable market data. Valuation techniques include
discounted cash flows or closely related listed product, as appropriate.
10. Financial instruments (continued)
(c)Valuation is based on inputs that cannot be observed using market data (unobservable inputs), including forward
electricity or commodity prices, energy volume or mine production, using valuation techniques such as discounted
cash flows or option pricing models, as appropriate. The change in valuation of our level 3 instruments for the period
to 30 June 2026 and 31 December 2025 is as follows:
30 June
2026
31 December
2025
Level 3 financial assets and liabilities
US$m
US$m
Opening balance
172
216
Currency translation adjustments
7
16
Total realised (losses)/gains included in net operating costs
(24)
31
Total unrealised gains included in net operating costs
61
136
Total unrealised gains/(losses) transferred into other comprehensive income through
cash flow hedges
154
(105)
Additions/acquisitions of financial assets and liabilities
2
85
Disposals/maturity of financial assets and liabilities
18
(207)
Closing balance
390
172
Net gains included in the income statement for assets and liabilities held at period
end
34
113
(d)Our Cash and cash equivalents of US$8,913 million (31 December 2025: US$8,872 million) includes US$2,788
million (31 December 2025: US$3,725 million) relating to money market funds which are treated as FVTPL under
IFRS 9 with the fair value movements reported as finance income.
(e)Investments in equity shares and funds include US$186 million (31 December 2025: US$240 million) of equity
shares, not held for trading, where we have irrevocably elected to present fair value gains and losses on revaluation
in other comprehensive income. The election is made at an individual investment level.
(f)Other investments, including loans, covers cash deposits in rehabilitation funds, government bonds, managed
investment funds and royalty receivables. Royalty receivables include amounts arising from our previously divested
coal businesses with a fair value of US$266 million (31 December 2025: US$275 million).
(g)Trade receivables include provisionally priced invoices. The related revenue is initially based on forward market
selling prices for the quotation periods stipulated in the contracts with changes between the provisional price and
the final price recorded separately within “Other revenue”. The selling price can be measured reliably for the
Group's products, as it operates in active and freely traded commodity markets. At 30 June 2026, US$938 million
(31 December 2025: US$1,431 million) of provisionally priced receivables were recognised.
(h)Level 3 derivatives mainly consist of derivatives embedded in electricity purchase contracts linked to the LME,
Midwest premium and billet premium with terms expiring between 2029 and 2036 (31 December 2025: 2026 and
2036), as well as renewable power purchase agreements which are linked to forward electricity prices with terms
expiring between 2026 and 2054 (31 December 2025: 2026 and 2054).
(i)Net debt derivatives include interest rate swaps and cross-currency swaps. 
(j)Trade and other financial payables comprise trade payables, other financial payables, accruals and amounts due to
equity accounted units.
There were no material transfers between level 1 and level 2, or between level 2 and level 3 in the
current or prior period.
Fair values disclosure of financial instruments
The following table shows the carrying value and fair value of our borrowings including those
which are not carried at an amount which approximates their fair value as at 30 June 2026 and
31 December 2025. The fair values of some of our financial instruments approximate their
carrying values because of their short maturity, or because they carry floating rates of interest.
30 June 2026
31 December 2025
Carrying
value
US$m
Fair
value
US$m
Carrying
value
US$m
Fair
value
US$m
Listed bonds(a)
17,141
16,851
17,336
17,148
Oyu Tolgoi project finance
3,277
3,439
3,755
3,990
Rincon funding facility(b)
158
158
Other
838
797
840
795
Total borrowings (including overdrafts)
21,414
21,245
21,931
21,933
(a)In 2025, we issued US$9 billion of fixed and floating rate SEC-registered debt securities. The bonds consist of eight tranches of
varying principal amount, tenor and coupon. One tranche consisting of US$500 million three-year notes is priced at a floating rate
coupon of Compounded SOFR plus 0.84% maturing in 2028, with the remaining seven tranches priced at fixed coupons ranging
between 4.375% and 5.875% and maturity dates ranging between 2027 and 2065.
(b)On 11 March 2026, we secured a US$1,175 million funding facility (the 'facility') from four international lenders, comprising the
International Finance Corporation, Inter-American Development Bank Invest, Export Finance Australia and the Japan Bank for
International Cooperation, to support the development of the Rincon lithium project in Argentina's Salta Province. The facility has a
ten-year term and matures in 2036. During the six months ended 30 June 2026, the amount drawn under the facility, net of
transaction costs was US$158 million.
Borrowings relating to listed bonds are categorised as level 1 in the fair value hierarchy while
those relating to project finance drawn down by Oyu Tolgoi (OT) use a number of level 3 valuation
inputs. Our remaining borrowings have a fair value measured by discounting estimated cash flows
with an applicable market quoted yield, and are categorised as level 2 in the fair value hierarchy.
The Group’s borrowings of US$21,414 million (31 December 2025: US$21,931 million) include
US$3,451 million (31 December 2025: US$3,795 million) of subsidiary entity borrowings that are
subject to various financial and general covenants, including, in some cases, environmental and
social covenants; the non-compliance with these covenants, if not remediated, would permit the
lender to immediately call the loan and borrowings. This includes our project finance borrowings in
OT and Rincon funding facility which require the maintenance of certain debt-to-equity ratios and
OT also requires maintenance of a debt service coverage ratio. Based on our forecasting, we
consider this risk of non-compliance with these covenants to be remote. The covenants with all
respective borrowers were in compliance as at 30 June 2026 and are expected to be in
compliance within 12 months after the reporting date.